489 related articles for article (PubMed ID: 30482205)
1. Breast cancer risk and serum levels of per- and poly-fluoroalkyl substances: a case-control study nested in the California Teachers Study.
Hurley S; Goldberg D; Wang M; Park JS; Petreas M; Bernstein L; Anton-Culver H; Nelson DO; Reynolds P
Environ Health; 2018 Nov; 17(1):83. PubMed ID: 30482205
[TBL] [Abstract][Full Text] [Related]
2. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of perfluoroalkyl substances and their association with osteoporosis in a population in Jeddah, Saudi Arabia.
Banjabi AA; Li AJ; Kumosani TA; Yousef JM; Kannan K
Environ Res; 2020 Aug; 187():109676. PubMed ID: 32485360
[TBL] [Abstract][Full Text] [Related]
4. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
[TBL] [Abstract][Full Text] [Related]
5. Perfluorinated alkylated substances serum concentration and breast cancer risk: Evidence from a nested case-control study in the French E3N cohort.
Mancini FR; Cano-Sancho G; Gambaretti J; Marchand P; Boutron-Ruault MC; Severi G; Arveux P; Antignac JP; Kvaskoff M
Int J Cancer; 2020 Feb; 146(4):917-928. PubMed ID: 31008526
[TBL] [Abstract][Full Text] [Related]
6. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
[TBL] [Abstract][Full Text] [Related]
7. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women.
Zhang S; Tan R; Pan R; Xiong J; Tian Y; Wu J; Chen L
J Clin Endocrinol Metab; 2018 Jul; 103(7):2543-2551. PubMed ID: 29986037
[TBL] [Abstract][Full Text] [Related]
8. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
[TBL] [Abstract][Full Text] [Related]
9. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.
Tsai MS; Miyashita C; Araki A; Itoh S; Bamai YA; Goudarzi H; Okada E; Kashino I; Matsuura H; Kishi R
Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29758015
[TBL] [Abstract][Full Text] [Related]
10. Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study).
Singer AB; Whitworth KW; Haug LS; Sabaredzovic A; Impinen A; Papadopoulou E; Longnecker MP
Environ Res; 2018 Oct; 166():78-85. PubMed ID: 29879567
[TBL] [Abstract][Full Text] [Related]
11. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
[TBL] [Abstract][Full Text] [Related]
12. Plasma Perfluoroalkyl and Polyfluoroalkyl Substances Concentration and Menstrual Cycle Characteristics in Preconception Women.
Zhou W; Zhang L; Tong C; Fang F; Zhao S; Tian Y; Tao Y; Zhang J;
Environ Health Perspect; 2017 Jun; 125(6):067012. PubMed ID: 28657892
[TBL] [Abstract][Full Text] [Related]
13. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal trends of per- and polyfluoroalkyl substances in children's serum.
Koponen J; Winkens K; Airaksinen R; Berger U; Vestergren R; Cousins IT; Karvonen AM; Pekkanen J; Kiviranta H
Environ Int; 2018 Dec; 121(Pt 1):591-599. PubMed ID: 30308470
[TBL] [Abstract][Full Text] [Related]
15. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
[TBL] [Abstract][Full Text] [Related]
16. Perfluorinated chemicals in blood serum of inhabitants in central Poland in relation to gender and age.
Góralczyk K; Pachocki KA; Hernik A; Struciński P; Czaja K; Lindh CH; Jönsson BA; Lenters V; Korcz W; Minorczyk M; Matuszak M; Ludwicki JK
Sci Total Environ; 2015 Nov; 532():548-55. PubMed ID: 26100734
[TBL] [Abstract][Full Text] [Related]
17. Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.
Kang H; Kim SH
Int J Hyg Environ Health; 2024 Jun; 259():114385. PubMed ID: 38676994
[TBL] [Abstract][Full Text] [Related]
18. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
[TBL] [Abstract][Full Text] [Related]
19. Per- and poly-fluoroalkyl substances (PFASs) in follicular fluid from women experiencing infertility in Australia.
Kim YR; White N; Bräunig J; Vijayasarathy S; Mueller JF; Knox CL; Harden FA; Pacella R; Toms LL
Environ Res; 2020 Nov; 190():109963. PubMed ID: 32745751
[TBL] [Abstract][Full Text] [Related]
20. Determinants of prenatal exposure to perfluoroalkyl substances in the Slovak birth cohort.
Richterová D; Fábelová L; Patayová H; Pulkrabová J; Lanková D; Rausová K; Šovčíková E; Štencl J; Hajšlová J; Trnovec T; Palkovičová Murínová Ľ
Environ Int; 2018 Dec; 121(Pt 2):1304-1310. PubMed ID: 30420127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
